Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.

Title:: Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Document type:: Clinical Trial; Clinical Trial, Phase I; Journal Article
Author(s):: Di Nicola, M; Carlo-Stella, C; Anichini, A; Mortarini, R; Guidetti, A; Tragni, G; Gallino, F; Del Vecchio, M; Ravagnani, F; Morelli, D; Chaplin, P; Arndtz, N; Sutter, G; Drexler, I; Parmiani, G; Cascinelli, N; Gianni, AM
Journal title abbreviation:: Hum Gene Ther
Year:: 2003
Journal volume:: 14
Journal issue:: 14
Pages contribution:: 1347-60
Language:: eng
Fulltext / DOI:: doi:10.1089/104303403322319426
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/14503969
Print-ISSN:: 1043-0342
TUM Institution:: Institut für Virologie
BibTeX

Occurrences: